Our data provide evidence that overall colon cancer-associated ADAM17 variants in the MPD and CD lack sufficient cell surface trafficking, but vary only slightly in their proteolytic activity in comparison to the wildtype (wt) construct. This evidence concerns the gene ADAM17 and malignant colon neoplasm.